$BBOT 4 SEC Filings

Filed On	Filing
23 Oct 2026	Form 4: Cobo Marc, Principal Accounting Officer Gave up 203 shares to cover exercise price or tax ($544)
05 Oct 2026	Form 4: Cobo Marc, Principal Accounting Officer Gave up 126 shares to cover exercise price or tax ($496)
05 Oct 2026	Form 4: Elmelech Idan, COO & Principal Financial Ofcr Gave up 343 shares to cover exercise price or tax ($1.35K)
05 Oct 2026	Form 4: Beltran Pedro, Director Gave up 1,047 shares to cover exercise price or tax ($4.13K)
05 Oct 2026	Form 4: Ben Yong, Chief Med & Dev Officer Gave up 1,047 shares to cover exercise price or tax ($4.13K)
14 Sep 2026	Form 4: Cobo Marc, Principal Accounting Officer Received 9,038 shares as a grant or award · Gave up 203 shares to cover exercise price or tax ($1.12K) · Granted 43,700 Stock Option (Right to Buy)
06 Jul 2026	Form 4: Ben Yong, Chief Med & Dev Officer Gave up 1,047 shares to cover exercise price or tax ($8.17K)
06 Jul 2026	Form 4: Chen Bihua, Director Disposed of 4,528,186 shares (Other Transaction) · Acquired 4,528,186 shares (Other Transaction)
06 Jul 2026	Form 4: Cobo Marc, Principal Accounting Officer Gave up 125 shares to cover exercise price or tax ($975)
06 Jul 2026	Form 4: Elmelech Idan, COO & Principal Financial Ofcr Gave up 343 shares to cover exercise price or tax ($2.68K)
06 Jul 2026	Form 4: Beltran Pedro, Director Gave up 1,047 shares to cover exercise price or tax ($8.17K)
18 Jun 2026	Form 4: Tipirneni Praveen P., Director Granted 31,675 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Mccormick Frank, Director Granted 31,675 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Lebowitz Peter F, Director Granted 7,289 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Kelleher Raymond J., Director Granted 31,675 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Chen Bihua, Director Granted 31,675 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Bauer Jake, Director Granted 31,675 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Kumar Neil, Director Granted 31,675 Stock Option (Right to Buy)
12 May 2026	Form 4: Elmelech Idan, COO & Principal Financial Ofcr Granted 758,222 Stock Option (Right to Buy)
12 May 2026	Form 4: Beltran Pedro, Director Granted 1,103,837 Stock Option (Right to Buy)

Comments